These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20667791)

  • 1. A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke.
    Kasner SE; Levine SR
    Lancet Neurol; 2010 Sep; 9(9):843-5. PubMed ID: 20667791
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteplase for ischaemic stroke--much sooner is much better.
    Saver JL; Levine SR
    Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous alteplase for ischaemic stroke.
    Albers GW; Olivot JM
    Lancet; 2007 Jan; 369(9558):249-50. PubMed ID: 17258646
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature.
    Cremer S; Berliner Y; Warren D; Jones AE
    CJEM; 2008 Nov; 10(6):575-8. PubMed ID: 19000355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteplase and ischaemic stroke: have new reviews of old data helped?
    Lindley RI; Wardlaw JM; Sandercock PA
    Lancet Neurol; 2005 Apr; 4(4):249-53. PubMed ID: 15778104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous recombinant tissue-type plasminogen activator in the extended time window and the US Food and Drug Administration: confused about the time.
    Wechsler LR; Jovin TG
    Stroke; 2012 Sep; 43(9):2517-9. PubMed ID: 22910892
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteplase for acute stroke revisited: the first 10 years.
    Lyden PD; Lees KR; Davis SM
    Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
    Külkens S; Hacke W
    Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteplase for stroke. American Heart Association explains how guidelines were formulated.
    Faxon D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092606
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute stroke management.
    Ducharme J; Currie T; Ovens H; Rutledge T; Thompson J
    Can Fam Physician; 2001 Dec; 47():2458. PubMed ID: 11785275
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous rtPA thrombolysis in acute ischemic stroke.
    Laloux P
    Acta Neurol Belg; 2001 Jun; 101(2):88-95. PubMed ID: 11486563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteplase for stroke. Uncertainty remains about efficacy.
    Mann H
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12089100
    [No Abstract]   [Full Text] [Related]  

  • 17. Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business?
    Southerland AM; Malik S; Johnston KC
    Neurology; 2011 Jul; 77(4):315-6. PubMed ID: 21715703
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 19. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 20. Alteplase for stroke. Patients and doctors are being misled by promotional pressures.
    Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.